Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors

Nature Genetics

Volumn 33, Issue 2, 2003, Pages 197-202

  Chen, Wen Yong ^a   Zeng, Xiaobei ^a   Carter, Mark G ^b   Morrell, Craig N ^c   Chiu Yen, Ray Whay ^a   Esteller, Manel ^d   Watkins, D Neil ^a   Herman, James G ^a   Mankowski, Joseph L ^c   Baylin, Stephen B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ALLELISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; GENE HIC1; HETEROZYGOSITY; HOMOZYGOSITY; KNOCKOUT MOUSE; LYMPHOMA; MALE; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN MODIFICATION; SARCOMA; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BLOTTING, SOUTHERN; DNA METHYLATION; FEMALE; GENE SILENCING; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASMS; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RABBITS; RIBONUCLEASE, PANCREATIC; SEX FACTORS; SULFITES; SYNDROME; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0037312934     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1077     Document Type: Article

References (23)

1. Wales, M.M. et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1, 570-577 (1995).
2. Bardwell, V.J. & Treisman, R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev. 8, 1664-1677 (1994).
3. Fujii, H. et al. Methylation of the HIC-1 candidate tumorsuppressor gene in human breast cancer. Oncogene 16, 2159-2164 (1998).
4. Issa, J.P., Zehnbauer, B.A., Kaufmann, S.H., Biel, M.A. & Baylin, S.B. HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res. 57, 1678-1681 (1997).
5. Kanai, Y. et al. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Hepatology 29, 703-709 (1999).
6. Carter, M.G. et al. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet. 9, 413-419 (2000).
7. DePinho, R.A. The age of cancer. Nature 408, 248-254 (2000).
8. Smith, G.S., Walford, R.L. & Mickey, M.R. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J. Natl. Cancer Inst. 50, 1195-1213 (1973).
9. Kawada, K. & Ojima, A. Various epithelial and non-epithelial tumors spontaneously occurring in long-lived mice of A/St, CBA, C578L/6 and their hybrid mice. Acta Pathol. Jpn. 28, 25-39 (1978).
10. Venkatachalam, S. et aL Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J. 17, 4657-4667 (1998).
11. + in intestinal adenomas from Min mice. Cancer Res. 54, 5947-5952 (1994).
12. Cichowski, K. et al. Mouse models of tumor development in neurofibromatosis type 1. Science 286, 2172-2176 (1999).
13. Guerardel, C. et al. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J. Biol. Chem. 276, 3078-3089 (2001).
14. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821-9826 (1996).
15. Harvey, M. et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5, 225-229 (1993).
16. Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. BioL 4, 1-7 (1994).
17. Krimpenfort, P., Quon, K.C., Mooi, W.J., Loonstra, A. & Berns, A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413, 83-86 (2001).
18. Arf predisposes mice to tumorigenesis. Nature 413, 86-91 (2001).
19. Baylin, S.B. & Herman, J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168-174 (2000).
20. Baylin, S.B., Belinsky, S.A. & Herman, J.G. Aberrant methylation of gene promoters in cancer - concepts, misconcepts, and promise. J. Natl. Cancer Inst. 92, 1460-1461 (2000).
21. Baylin, S.B. & Herman, J.G. Promoter hypermethylation - can this change alone ever designate true tumor suppressor gene function? J. Natl. Cancer Inst. 93, 664-665 (2001).
22. Frommer, M. et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89, 1827-1831 (1992).
23. Bar-Peled, M. & Raikhel, N.V. A method for isolation and purification of specific antibodies to a protein fused to the GST. Anal. Biochem. 241, 140-142 (1996).